Vivos announces deal with Lincare

LITTLETON, Colo. – Vivos Therapeutics, a medical technology company that makes oral appliances for patients suffering from mild-to-moderate obstructive sleep apnea and snoring in adults, has signed a distribution agreement with Lincare. 

The agreement follows a successful a distribution pilot with Lincare and marks an important milestone in Vivos’ strategy to engage with leading durable medical equipment companies in the United States. Lincare will have a six-month exclusive deal to distribute certain designated Vivos devices. 

“We are pleased to offer oral appliances as an alternative treatment to our non-compliant CPAP patients,” said Jeff Barnhard, CEO of Lincare. “Finding the best solutions for our sleep apnea patients has always been a high priority for Lincare. We look forward to working alongside Vivos-trained dentists.”  

The Vivos Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and associated protocols alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and/or palate. It opens airway space and may significantly reduce symptoms and conditions associated with mild-to-moderate OSA, such as lowering apnea hypopnea index scores. 

The deal gives Vivos access to Lincare’s large patient census, which includes about 1.8 million respiratory patients. 

“Lincare is one of the market leaders in this sector, and we are pleased to join forces with them in this pioneering initiative,” said Kirk Huntsman, chairman and CEO of Vivos. “It is well known that a sizable number of sleep apnea patients discontinue CPAP usage in search of alternative treatment options. This important collaboration between a national supplier of DME like Lincare and an innovative oral appliance company like Vivos will bring fresh solutions and relief to patients currently seeking alternatives.” 

Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children.